Abstract
Mental health stigma remains one of the most pervasive barriers to accessing care, often preventing individuals from utilizing available resources at community mental health centers. This paper investigates the predictive relationship between community-based stigma reduction campaigns and subsequent mental health service utilization through a comprehensive longitudinal cohort study. Over a two-year period, a large-scale cohort was observed to determine whether exposure to targeted anti-stigma interventions directly translates into increased clinical engagement. By employing rigorous observational methodologies and detailed tracking of outpatient visits, crisis interventions, and therapy enrollments, this study provides an extensive analysis of behavioral changes at the community level. The research addresses critical gaps in the understanding of how public health messaging influences actual healthcare-seeking behavior, moving beyond self-reported attitude changes to objective metrics of facility usage. The findings elucidate the demographic and psychosocial variables that most strongly predict a transition from campaign exposure to active service utilization. Ultimately, this work offers profound implications for public health policymakers and community mental health administrators, demonstrating that well-designed stigma reduction campaigns can serve as effective catalysts for increasing healthcare access and improving overall population health outcomes.References
1. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Population Health. BRFSS Prevalence & Trends Data. 2025. Available online: https://www.cdc.gov/brfss/brfssprevalence/ (accessed on 15 May 2026).
2. Kozhoyarova, A.; Sargsyan, A.; Goncharova, O.; Kadyrov, A. Who is doing worse? Retrospective cross-sectional study of TB key population treatment outcomes in Kyrgyzstan (2015–2017). J. Infect. Dev. Ctries 2020, 14, 101S–108S.
3. Liyew, A.M.; Clements, A.C.A.; Akalu, T.Y.; Gilmour, B.; Alene, K.A. Ecological-level factors associated with tuberculosis incidence and mortality: A systematic review and meta-analysis. PLoS Glob. Public Health 2024, 4, e0003425.
4. Martin, S.S.; Aday, A.W.; Almarzooq, Z.I.; Anderson, C.A.M.; Arora, P.; Avery, C.L.; Baker-Smith, C.M.; Barone Gibbs, B.; Beaton, A.Z.; Boehme, A.K.; et al. 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation 2024, 149, e347–e913, Erratum in Circulation 2024, 149, e1164. https://doi.org/10.1161/CIR.0000000000001247. Erratum in Circulation 2025, 151, e1095. https://doi.org/10.1161/CIR.0000000000001344. [ Central]
5. Darisheva, M.; Tracy, M.; Terlikbayeva, A.; Zhussupov, B.; Schluger, N.; McCrimmon, T. Knowledge and attitudes towards ambulatory treatment of tuberculosis in Kazakhstan. BMC Health Serv. Res. 2020, 20, 563.
6. WHO Regional Office for Europe. Extensive Review of Tuberculosis Prevention, Control and Care in Kazakhstan, 10–16 May 2012; World Health Organization: Geneva, Switzerland, 2014; Available online: https://apps.who.int/iris/handle/10665/131834 (accessed on 4 July 2025).
7. Centers for Disease Control and Prevention (CDC). Tuberculosis (TB): TB Risk Factors; CDC: Atlanta, GA, USA, 2021. Available online: https://www.cdc.gov/tb/risk-factors/index.html (accessed on 6 July 2025).
8. United States Department of Agriculture Economic Research Service. Food Security in the U.S.: Key Statistics & Graphics. 2021. Available online: https://www.ers.usda.gov/topics/food-nutrition-assistance/food-security-in-the-us/key-statistics-graphics (accessed on 23 March 2025).
9. Kolahdooz, F.; Jang, S.L.; Deck, S.; Ilkiw, D.; Omoro, G.; Rautio, A.; Pirkola, S.; Møller, H.; Ferguson, G.; Evengård, B.; et al. A Scoping Review of the Current Knowledge of the Social Determinants of Health and Infectious Diseases (Specifically COVID-19, Tuberculosis, and H1N1 Influenza) in Canadian Arctic Indigenous Communities. Int. J. Environ. Res. Public Health 2024, 22, 1.
10. Mississippi Behavioral Risk Factor Surveillance System (BRFSS), 2012–2021 Trend Report. Available online: https://msdh.ms.gov/page/resources/19989.pdf (accessed on 12 February 2025).
11. Chaturvedi, A.; Zhu, A.; Gadela, N.V.; Prabhakaran, D.; Jafar, T.H. Social Determinants of Health and Disparities in Hypertension and Cardiovascular Diseases. Hypertension 2024, 81, 387–399. [ Central]
12. Ullah, H.; Ahmed, H.; Salman, A.; Iqbal, R.; Hussaini, S.J.; Malikzai, A. The rising tide of tuberculosis in Pakistan: Factors, impact, and multi-faceted approaches for prevention and control. Health Sci. Rep. 2024, 7, e70130.
13. Rigotti, N.A.; Kruse, G.R.; Livingstone-Banks, J.; Hartmann-Boyce, J. Treatment of Tobacco Smoking: A Review. JAMA 2022, 327, 566–577.
14. Glushkova, N.; Semenova, Y.; Sarria-Santamera, A. Editorial: Public health challenges in post-Soviet countries during and beyond COVID-19. Front. Public Health 2023, 11, 1290910.
15. American Lung Association. Tobacco Facts. Available online: https://www.lung.org/research/sotc/facts (accessed on 22 March 2025).
16. Kurylek, W. Are Natural Language Processing Methods Applicable to EPS Forecasting in Poland? Data Sci. Financ. Econ. 2025, 5, 35–52.
17. Drope, J.; Liber, A.C.; Cahn, Z.; Stoklosa, M.; Kennedy, R.; Douglas, C.E.; Henson, R.; Drope, J. Who’s still smoking? Disparities in adult cigarette smoking prevalence in the United States. CA Cancer J. Clin. 2018, 68, 106–115.
18. Nain, P.; Stabellini, N.; Makram, O.M.; Rast, J.; Yerraguntla, S.; Gopu, G.; Bhave, A.; Seth, L.; Patel, V.; Jiang, S.; et al. Adverse social determinants of health elevate uncontrolled hypertension risk: A cardio-oncology prospective cohort study. JNCI Cancer Spectr. 2024, 8, pkae064. [ Central]
19. Park, H.; Fan, P.; John, R.; Chen, J. Urbanization on the Mongolian Plateau after economic reform: Changes and causes. Appl. Geogr. 2017, 86, 118–127.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Authors
